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ABSTRACT 
 
 
Functional Vasodilation and Vascular Reactivity in Arteriolar Collaterals in the 
Spinotrapezius of Males and Females 
 
 
Britta Nelson 
 
Peripheral arterial occlusive disease (PAOD) occurs when there is narrowing or 
blockage of the peripheral arteries that carry blood to the extremities, most commonly the 
legs. The most common symptom of PAOD is intermittent claudication, or ischemic pain 
during exercise. Women with PAOD experience a greater extremity functional 
impairment than men. Since impaired vasodilation might cause the ischemic pain from 
PAOD, we should evaluate vasodilation post ligation in males and females in collateral 
vessels, which connect two arterial segments to maintain blood flow to an otherwise 
hypoxic area. First, we need to examine collateral vasodilation in unoperated male and 
female animals. The goal of this study was to create a consistent protocol to measure 
functional vasodilation in collaterals of male and female C57Bl/6 mice, and to test the 
hypothesis that unoperated male and female C57Bl/6 mice exhibit equal vasodilation. 
The spinotrapezius muscle allows for clear visualization of intramuscular collaterals, 
which in animal models and patients will undergo arteriogenesis in response to an arterial 
occlusion. The muscle was stimulated using microelectrodes to induce endogenous 
vasodilation, and resting and dilated diameters were recorded. Diameters obtained from 
covering the preparation with plastic wrap and irrigating the preparation with a 
physiological salt solution (PSS) were also compared to determine the effect of the 
preparation of the muscle on vasodilation. As expected, there was no difference between 
the resting diameters or the dilated diameters of males and females when preparations 
were irrigated with PSS. Additionally, the preparation of the muscle had no effect on 
vasodilation. These findings suggest further investigation into vasodilation post ligation 
in males and females in collateral vessels. 
 
 
 
 
 
 
 
 
 
 
 
 
Keywords: arteriogenesis, ischemia, peripheral arterial occlusive disease, vasodilation, 
spinotrapezius 
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CHAPTER 1: Introduction 
 
1.1 Clinical Relevance: Ischemic Disease  
 
 Ischemic disease is the major cause of mortality in Western civilization [1]. 
Ischemic disease develops when an atherosclerotic plaque prevents downstream tissue 
from receiving sufficient blood flow, causing tissue necrosis if the arteries become 
completely occluded (Figure 1) [2,3]. Peripheral arterial occlusive disease (PAOD) 
occurs when the atherosclerotic plaques affect the peripheral arteries that carry blood to 
the extremities, most commonly the legs [4]. The disease affects approximately 8 million 
people in the US, while the general population awareness of the disease is only around 
25% [4]. Women with PAOD have a worse physical health status and health-related 
quality of life, and a greater lower extremity functional impairment compared with men 
[5,6].  
 
Figure 1. Peripheral Arterial Occlusive Disease. A normal artery compared to an 
atherosclerotic artery in a patient with PAOD [5]. 
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1.2 Symptoms and Diagnosis of Peripheral Arterial Occlusive Disease 
 
The most common symptom of PAOD is intermittent claudication, or ischemic 
pain during exercise, in the legs [4]. For example, patients may feel pain, numbness, or 
heaviness in the buttock, hip, thigh, or calf when walking or climbing the stairs [4]. The 
skin may appear cyanotic, and there may be ulcers on the toes, feet, or legs [2]. High risk 
factors for PAOD include smoking, high blood pressure, diabetes, high cholesterol, and 
age over 60 [4]. Patients who exhibit intermittent claudication are diagnosed using a non-
invasive test called an ankle-brachial index, in which the systolic blood pressure in the 
tibial artery is compared with the systolic blood pressure in the brachial artery, before and 
after exercise [4,7]. A low ABI index (a comparison of the readings) is indicative of 
PAOD, meaning there is a lower blood pressure in the ankles than in the arms, caused by 
the narrowing of arteries and blockage of blood flow [8]. Women have a lower mean ABI 
and are more likely than men to have an ABI of less than 1.0 [9]. The extent of collateral 
networks is related to prognosis, which might be an explanation of why females are 
worse off than males [10]. 
 
1.3 Male and Female Differences in Vasodilation 
            There exist gender differences in vasodilation capabilities. Immediately following 
femoral artery ligation in mice, there is no difference in acetylcholine (Ach), a nitric 
oxide dependent vasodilator, induced reductions in hindlimb vascular resistance between 
males and females [10]. Females exhibited a greater reduction in vascular resistance than 
males after adding L-NAME, a nitric oxide synthase inhibitor [10]. Ten days post 
ligation, females exhibited less Ach induced vascular resistance than males, and adding 
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L-NAME inhibited Ach induced vascular resistances more in females than in males [10]. 
Ten days post ligation, females also exhibited less nitroglycerin, a smooth muscle cell 
dependent vasodilator, vascular resistance when compared to males [10]. This suggests 
that as collaterals remodel, males develop a more robust nitric oxide synthase vascular 
resistance than females [10]. Possible reasons of early dilatory impairment are impaired 
smooth muscle cell function, impaired endothelial cell function, or a combination of both 
[10]. At baseline, females have higher levels of VEFG and eNOS, but ten days post 
femoral artery ligation, males have higher levels of VEGF and eNOS [10]. The impaired 
recovery of flow of females is associated with multiple factors, including decreased 
collateral remodeling, ased vasoconstrictor activity [10].   
            Vasodilators are currently used as a therapy for peripheral arterial occlusive 
disease, such as cilostazol and pentoxifylline [11,12]. Pentoxifylline works by helping 
blood flow more easily through narrowed arteries, increasing blood flow and therefore 
oxygen levels to the muscles [12,13]. Cilostazol is an anticoagulant drug and a 
vasodilator that can be used to improve blood flow [11]. Men and women show no 
differences in the treatment effects of Cilostazol [6].  
 
 
1.4 Previous Work 
  
 Vasodilation of collateral vessels can be used as an alternative treatment for 
patients who are not candidates for surgical intervention. Natural bypasses, or collateral 
vessels, connect two arteriolar segments [14]. Collaterals are the main site of resistance to 
blood flow in the ischemic zone, so it is important to study how each zone reacts to 
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occlusion and arteriogenesis [15]. C57Bl/6 mice have a high density of pre-existing 
collaterals (PECs) [16].  
 Collaterals consist of three zones: the reentry, close to the site of the occlusion, 
the stem at the distal aspect, where blood flow from another tree is entering, and the 
midzone, between the two regions. At rest, the net shear stress in collateral midzone is 
zero, but post occlusion, there is an increase in shear stress in the vessels (Figure 4) [17]. 
The amount of shear stress in the different zones potentially causes different zones to 
have different degrees of remodeling (ref). At rest, there is no net blood flow in the 
collateral midzone [14]. However, following an occlusion, there is an increase in the 
pressure gradient across the collaterals, which induces arteriogenesis - a shear stress-
driven process in which PECs outwardly remodel to become conduit vessels, providing 
an alternate pathway for blood to travel around an occluded artery (Figure 3) [18]. When 
an atherosclerotic plaque blocks a vessel, there is a decrease in downstream pressure and 
flow is redirected through PECs, increasing the shear stress in the collaterals. The 
increased shear stress activates endothelial cells, which express cell-surface adhesion 
molecules and proinflammatory cytokines to recruit and activate monocytes to the vessel 
wall [19]. The extravasated macrophages secrete matrix metalloproteinases (MMPs) that 
degrade the extracellular matrix, vascular endothelial growth factor (VEGF) that causes 
endothelial proliferation, and platelet-derived growth factor (PDGF), which attracts 
smooth muscle cells [19,20]. As a result, vessels enlarge, resulting in a larger resting 
diameter (ref). This inhibits the increase in shear stress, halting arteriogenesis. It is 
imperative to visualize the entire collateral to understand how the different collateral 
zones are affected by occlusion and arteriogenesis.  
	 	 		
	 11	
 
Figure 3. Arteriogenesis. Arteriogenesis occurs due to a decrease in downstream tissue 
following the occlusion of an artery. Blood flow is redirected through collaterals from the 
increased shear stress in the vessels [21]. 
  
 
Figure 4. Collateral Blood Flow. Normal blood flow in a collateral compared to blood 
flow in a collateral post occlusion [17]. 
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1.5 Purpose of Current Study 
 The purpose of this study was to assess vasodilation in PECs in the spinotrapezius 
of C57Bl/6 males and females. If vasodilation is used as a treatment for PAOD, we want 
to see if there are any differences in the dilatory capabilities of males and females. Unlike 
previous studies in the hindlimb, all zones of a complex collateral circulation can be 
readily visualized in the spinotrapezius. Therefore, we can study how each zone of the 
collateral circulation is affected by occlusion and arteriogenesis.  
 
The specific aims of this study are as follows: 
Specific Aim 1: Develop a protocol for consistent functional vasodilation in the 
spinotrapezius of C57Bl/6 males and females.  
  Corollary to Specific Aim 1: Test the hypothesis that there is no difference 
in resting and dilated vessel diameter measurements of female mice when irrigating the 
preparation with physiological salt solution and covering the preparation with plastic 
wrap. 
Specific Aim 2: Test the hypothesis that females and males exhibit equal 
functional vasodilation. 
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CHAPTER 2: Methods 	
2.1 Animal Husbandry 	
 All procedures for this study were performed according to protocols approved by 
the Institutional Animal Care and Use Committee (IACUC) of California Polytechnic 
State University San Luis Obispo. Six male C57Bl/6 mice, with average weights of 23 ± 
1 g, and six female C57Bl/6 mice with average weights of 18 ± 0.4 g, aged between 7-9 
weeks were used in this study. Mice were housed in micro-isolator cages within a 
temperature-controlled room (69-73°F) in the University Vivarium. The room was 
monitored daily and maintained 12-hour light/dark cycles. Males and females were 
segregated by sex and each cage housed a maximum of four mice. Mice were provided 
with rodent chow, water, bedding, a plastic ‘mouse house’, a tunnel tube, and a chew toy. 	
2.2 Mouse Preparation 	
 Each mouse was initially anesthetized in an induction chamber with 5% vaporized 
isoflurane in oxygen flowing at 0.8-1.2 l·min-1. The mice were weighed and transferred to 
a preparatory bench where anesthesia was maintained with 2-3% isoflurane at a flow rate 
of 0.8-1.2 1⋅min-1. Trimming clippers and depilatory cream were used to remove the hair 
on the anterior dorsal aspect and the anterior ventral aspect of the mouse. The mice were 
then transferred to a heat pad on the surgical stage, in which core body temperature was 
maintained at 35°C via rectal thermister feedback. The left or right spinotrapezius was 
exposed by an initial skin incision at the caudal end of the muscle, followed by the 
removal of skin and connective tissue via blunt dissection; the contralateral side was then 
exposed, alternating between the left and right spinotrapezius for each procedure. The 
ipsilateral side was continually irrigated with physiological salt solution (PSS) containing 
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(in mM) 131.9 NaCl, 18 NaHCO3, 4.7 KCL, 2 CaCa2, and 1.17 MgSO4 to maintain a 
physiologic pH and temperature and ionic concentrations similar to the extracellular fluid 
to avoid creating any concentration gradients. Following exposure, the entire muscle was 
covered with plastic wrap, and the mouse was moved to supine position. An initial 
incision was made in the center of the chest, and identified, and after overlying 
connective tissue was removed by blunt dissection, was catheterized. The catheter lined 
with heparinized saline (1 mg/mL) was used to deliver 0.3mL of FITC-conjugated 
dextran (250,000 MW, Sigma Aldrich). 0.005 mL of the FITC dextran and heparinized 
saline solution was injected about every hour throughout the experiment. 
 
Figure 5. Catheter Placement. A) A silk suture is placed around the upstream portion of 
the jugular vein, and a clamp is placed around the downstream portion. B) The catheter is 
placed in the jugular vein and a suture is tied around it to hold it in place. 
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2.3 Preparation Irrigation 
 
 	 	
Figure 6. Superfusion Setup. 
 
 
 After the catheter was placed, the mouse was returned to the prone position. The 
plastic wrap was removed from the muscle. Collateral arterioles were visualized using an 
intravital microscope (Olympus BXFM 5x). Physiological salt solution was prepared 
fresh the day of each procedure from a stock solution, as described above. The PSS was 
bubbled with a 5% CO2 - 95% N2 mixture to deoxygenate the solution and maintain a pH 
of ~7.4  and flowed over the tissue at rate of ~2 mL⋅min-1 and a temperature of 35°C. The 
same procedure was followed for the contralateral muscle.  
 
2.4 Functional Vasodilation 
 
 The spinotrapezius was exposed, as described above, and the overlying fascia was 
gently removed. Two tungsten microelectrodes were placed lateral to the spine at the 
caudal end of the muscle to induce contraction by electrical field stimulation. Proper 
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placement of the electrodes was determined with a brief set of 2mA square waves of 200 
µs duration at 1 Hz (LabChart and a PowerLab Data Acquisition System, 
ADInstruments). Following electrode placement, the muscle was covered with plastic 
wrap to prevent desiccation, collateral arterioles were identified with the intravital 
microscope, and the preparation was given 30 minutes to equilibrate. After capturing 
images of the collaterals at rest, the muscle was stimulated for 90 seconds with a set of 
2mA square waves of  200 µs duration at 8 Hz, and a second set of images were captured 
immediately following the stimulation cessation. The plastic wrap was removed from the 
contralateral muscle and the PSS was superfused over the muscle according to the 
specifications outlined in Section 2.4. The preparation was given 30 minutes to 
equilibrate. Images were captured at rest, and the muscle was stimulated as described 
above. A second set of images were captured immediately following the stimulation 
cessation. Upon completion of the experiment, the mouse was euthanized by cervical 
dislocation.  
 
2.5 Imaging 
 
 Images were captured using an Olympus BXFM bright field microscope with a 5x 
objective. QCapture Pro Image and Analysis software was used to capture sequences of 
fifteen images. 
 
2.6 Data Analysis 
 Vessel diameters were measured using ImageJ analysis software. The diameters 
before and after muscle stimulation were measured and the percent change was calculated 
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using the difference of the dilated and resting diameters divided by the resting diameter 
and multiplied by one hundred. Differences in resting and stimulated diameters of males 
and females, with PSS irrigation or plastic wrap were determined using a paired t-test. 
Differences in diameters of males and females, resting and dilated, were determined 
using an independent t-test. Differences in diameters of females, with PSS irrigation or 
plastic wrap, and differences in percent change of diameters, were determined using an 
independent t-test. A p-value of less than 0.05 was used to denote statistical significance. 
Data are expressed as mean ± standard error. 
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CHAPTER 3: Results 
 The goal of this study was to develop a protocol to measure functional 
vasodilation in the spinotrapezius collaterals of male and female C57Bl/6 mice. To 
accomplish this goal, we compared resting and dilated diameters of male and female 
C57Bl/6 mice, when the preparation was covered with plastic wrap and when it was 
irrigated with a physiological salt solution. 
 Four collateral measurements were taken in each muscle, in two collaterals per 
muscle. There was up to a 5 µm variability between different collaterals of the same 
branching order on different muscles of each sex. The anatomical variability of the 
collaterals was sufficiently small, meaning that similar collaterals could be measured in 
different animals. 
 As expected, there was no difference between the resting diameters of males and 
females when preparations were irrigated with PSS, 21 ± 2 µm and 19 ± 1 µm, 
respectively, (Figure 7C). Also as predicted, there was no difference between the dilated 
diameters of males and females when preparations were irrigated with PSS, 37 ± 2 µm 
and 33 ± 2 µm, respectively, (Figure 7C). Vasodilation in male mice when the 
preparation was irrigated with PSS involved an 81.4 ± 7.0 % above resting, which was 
not different from the female dilation of 77.9 ± 8.8 %, (Figure 7D). 
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Figure 7. Spinotrapezius C57Bl/6 Collateral Diameters. Representative 
photomicrographs of resting (A) and dilated (B) collateral vessel measurements in 
ImageJ in the midzone. C) Diameters in microns pre and post muscle stimulation via 
electrodes with superfusion (n=8, *, p<0.05). D) Percent changes between collateral 
vessels pre and post muscle stimulation via electrodes (n=8, *, p<0.05).  
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To determine the effect of the preparation of the muscle on vasodilation, we 
performed functional vasodilation after covering the preparation with plastic wrap, and 
irrigating the preparation with PSS. There was no difference between the resting 
diameters of females when the preparation was superfused with PSS versus covering the 
preparation with plastic wrap, 19 ± 1 µm and 19 ± 1 µm, respectively (Figure 8A). 
Similarly, there was no difference between the dilated diameters of females when the 
preparation was superfused with PSS versus covering the preparation with plastic wrap, 
33 ± 2 µm and 31 ± 1 µm, respectively, (Figure 8A). Vasodilation in female mice when 
the preparation was superfused with PSS involved a 77.9 ± 8.8 % above resting. This was 
not different from the female dilation when plastic wrap covered the preparation 65.7 ± 
7.7% (Figure 8B).  
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Figure 8. Female Spinotrapezius Collateral Diameters. A) Diameters in microns pre 
and post muscle stimulation via electrodes with superfusion and plastic wrap (n=8, *, 
p<0.05). B) Percent changes between collateral vessels pre and post muscle stimulation 
via electrodes with superfusion and plastic wrap (n=8, *, p<0.05). 
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CHAPTER 4: Discussion 
 Patients with PAOD experience intermittent claudication that is caused by the 
blockage of an artery, preventing downstream tissue from receiving sufficient blood flow. 
Collateral vessels act as natural bypasses to provide oxygen to tissue that would 
otherwise be hypoxic. Collateral circulation is the primary site of resistance to blood flow 
downstream. Impaired vasodilation of the collaterals might explain intermittent 
claudication.  
 Vasodilation occurred in collaterals of males and females. There was no 
difference between the diameters of male and female arterioles at rest or dilated, or in the 
percent change. These findings are comparable to those of an isolated vessel preparation 
of gracilis muscle arterioles of male and female wild type mice, where unoperated males 
and females exhibited comparable vasodilation [22]. The change in diameter of females 
was 5-7% less than that of males as pulsatile flow increased, which is comparable to the 
3% difference in the change in diameter between males in females in this study [22]. 
 PSS was superfused over the muscle to maintain physiologic conditions of the 
muscle. Superfusion is advantageous because it is an endogenous method of covering the 
muscle preparation. However, the setup of superfusion is complicated, and requires the 
user to maintain an end temperature of 35°C on the muscle. PSS is heated to 50°C in a 
volumetric flask and poured into a heated 60 mL syringe. This caused a change in 
temperature of the PSS in the 60 mL syringe, causing the temperature of the tubing to 
fluctuate throughout the experiment, yielding a temperature of 33°C - 37°C on the 
muscle. This could have led to inaccuracies in diameter measurements. There was a 
difference between the resting and dilated diameters of females when preparations were 
	 	 		
	 23	
covered with plastic wrap. There was no difference between diameters or percent change 
of females when preparations were covered with plastic wrap or irrigated with PSS. 
Using plastic wrap to cover the muscle during functional vasodilation is a reliable method 
to prevent tissue desiccation.  
 The resting and dilated diameters of males, 21 ± 2 µm and 37 ± 2 µm, and of 
females, 19 ± 1 µm and 33 ± 2 µm, when the preparation was superfused with PSS are 
similar to those of other intravital studies of functional vasodilation. Second order 
arterioles in the gluteus maximus muscle of unoperated male C57Bl/6 mice dilate from 
20 µm to 42 µm in response to a rhythmic contraction via electrodes at 2 Hz and 8 Hz in 
a randomized order for 30 seconds [23]. Although the muscles are of different sizes, both 
are skeletal muscles that contain arterioles of similar sizes that exhibit comparable 
vasodilation [23].  
Future work to expand this study could include comparing the baseline 
measurements of resting and dilated diameters to measurements following the ligation of 
a feed artery in male and female C57Bl/6 mice. This comparison would investigate the 
dilatory capabilities pre-existing collaterals in males and females post-occlusion, to 
determine when the vessels are able to dilate, restoring blood flow control to the ischemic 
area of patients with PAOD.  Further, a study could be done comparing the dilatory 
capabilities post-occlusion of pre-existing collaterals in C57/Bl6 mice to newly formed 
arterialized capillaries in BALB/c mice, to investigate any differences in their dilatory 
capabilities. This is important to study because some patients have pre-existing collaterals 
while others do not. 
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 Vasodilation of collateral vessels could be an effective treatment for patients with 
PAOD. It is important to investigate any differences in the dilatory capabilities of males 
and females to provide a better understanding of male and female differences in the 
prognosis of PAOD.   
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CHAPTER 5: Apendices 
 
 
 
Date____________              Functional Vasodilation with Superfusion                    Initials ______ 
 
Mouse Information 
DOB: _______________________ 
Sex: ________________________ 
Tag: ________________________ 
Genotype/Strain: _____________ 
Cage: _______________________ 
Weight: _____________________ 
 
Materials 
____1. Standard pattern forceps 
____2. 545s 
____3. Iris scissors 
____4. Microdissection scissors 
____5. S&Ts (2) 
____6. Volumetric flask 
____7. Kim wipes 
____8. 20x PSS 
____9. 20x NaHCO3 
____10. Bubbler 
____11. 60mL syringe 
____12. Catheter 
____13. FITC Dextran 
____14. Vascular clamp 
____15. Tungsten microelectrodes 
____16. Plastic wrap 
 
Equipment Preparation 
____17. Turn on ultrasonic bath to 50°C 
____18. Transfer 50mL of 20x PSS into 1 L  
volumetric flask  
____19. Transfer50mL of 20x NaHCO3 into 1L  
volumetric flask 
____20. Dilute PSS & NaHCO3 to 1L with 18MΩ  
H20 
____21. Place 1L volumetric flask in water bath 
____22. Fill syringe in syringe heater with 50mL of 
1x PSS & turn on syringe heater 
____23. Place thermistor in syringe heater 
 
Animal Preparation 
____24. Weigh animal in weigh boat 
____25. Place animal in anesthesia box 
____26. Open the oxygen cylinder and set anesthesia  
machine flow meter to 0.8-1.2 l·min-1. 
____27. Anesthetize animal with 5% isoflurane 
____28.  Reduce flow rate to 0.8-1.2 l·min-1. and     
the isoflurane to 2-3% 
____29. Lay animal supine on preparation bench  
with nose in nose cone 
____30. Use trimming clippers & depilatory cream to  
remove on anterial dorsal and anterior  
ventral aspects 
____31. Transfer mouse to heat pad  
____32. Insert rectal probe and set thermo-controller  
to 35°C 
 
Protocol 
____33. Make 1cm incision at caudal end of  
spinotrapezius 
____34. Extend incision cranially to the fat pad 
____35. Blunt dissect connective tissue 
____36. Cover muscles with plastic wrap 
____37. Move animal to supine position 
____38. Make incision in center of chest and extend  
____39. Identify jugular vein 
____40. Tie silk suture around jugular vein upstream 
____41. Place vascular clam around jugular vein  
downstream 
____42. Poke hole to insert catheter between suture  
and clamp 
____43. Deliver hepanarized saline and FITC  
dextran 
____44. Flip mouse to supine position 
____45. Open stockcock on delivery tubing to check  
flow rate of superfusion solution and use 
thermistor to measure temperature 
____46. Adjust flow rate or temperature to achieve  
~2mL·min-1 and 35°C at tip 
____47. Place electrodes as close together as possible  
in clay and place electrodes lateral to the  
spine, at the caudal end of the muscle 
____48. Stimulate the muscle at frequency 1 Hz,  
duration 200 us, and 2 mA to ensure 
electrode placement stimulates the muscle 
____49. Place saran wrap over the exposed muscle  
____50. Allow a 30 minute time period to pass  
between test stimulation and taking the first  
measurement 
____51. Take rest measurements with BFXM 
____52. Set frequency to 8 Hz and keep other  
settings the same 
____53. Stimulate the muscle for 90 seconds 
____54. Immediately take dilated measurements 
____55. Perform the same procedure on the control  
limb 
____56. Cervical dislocation to euthanize animal 
